A Focus on VEGF TKIs

Experts discuss the optimal use of VEGF-targeted tyrosine kinase inhibitors for patients with GI malignancies in this this podcast series that includes downloadable summary slidesets.

Share

Program Content

Activities

  • Sequencing Later-Line CRC Tx
    Optimizing the Timing and Sequencing of Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 29, 2021

    Expires: April 28, 2022

  • <i>Pearls</i>: Later-line CRC Tx
    Podcast Pearls: Optimizing the Timing and Sequencing of Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 29, 2021

    Expires: April 28, 2022

  • Dosing in Later-Line CRC Tx
    Optimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 21, 2021

    Expires: October 20, 2022

  • <i>Pearls:</i> Dosing Rego/TAS-102
    Podcast Pearls
    Optimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 21, 2021

    Expires: October 20, 2022

  • Key Factors in Later-Line CRC Tx
    Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 17, 2021

    Expires: December 16, 2022

  • <i>Pearls</i>: Key Factors in Later-Line CRC Tx
    Podcast Pearls: Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 20, 2021

    Expires: December 19, 2022

  • Rego and TAS-102 for CRC
    Evolving Treatment Landscape With Regorafenib and TAS-102 in Metastatic Colorectal Cancer
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 06, 2022

    Expires: April 05, 2023

  • <i>Pearls</i>: Rego and TAS-102 for CRC
    Podcast Pearls: Evolving Treatment Landscape With Regorafenib and TAS-102 in Metastatic Colorectal Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 06, 2022

    Expires: April 05, 2023

Faculty

cover img faculity

Nilofer S. Azad, MD

Associate Professor, Oncology
Johns Hopkins
Baltimore, Maryland

cover img faculity

Chiara Cremolini, MD, PhD

Medical Oncologist
Unit of Medical Oncology 2
Azienda Ospedaliero-Universitaria Pisana
Professor
Department of Translational Research and New Technologies in Medicine and Surgery
University of Pisa
Pisa, Italy

cover img faculity

Joleen Hubbard, MD

Associate Professor
Gastrointestinal Oncologist
Medical Oncology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Teresa Macarulla, MD

Medical Oncologist
Vall d Hebron Institute of Oncology
Barcelona, Spain

cover img faculity

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

cover img faculity

Kanwal Raghav, MD

Associate Professor
Gastrointestinal Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Rachel Riechelmann, MD, PhD

Director, Clinical Oncology
AC Camargo Cancer Center
Sao Paulo, Brazil

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma